![]() BioLoomics BioLoomics is a preclinical-stage biotechnology company leveraging the directed evolution of antibodies in human cells to create target-degrading antibodies. | |||
Founding Date | Founding Date 2014 | Founding Date 2014 | Founding Date 2019 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Pessac, FR HQ | Locations Beijing, CN HQ San Francisco, US | Locations Boulder, US HQ |
Employees | Employees 176% decrease | Employees 336% increase | Employees 1616% decrease |
Funding | |||
Latest funding round | Latest funding round $ 6.2m (about 8 years ago) | Latest funding round $ 25k (over 11 years ago) | Latest funding round $ 8.7m (over 2 years ago) |
Total funding raised | Total funding raised $ 8.9m | Total funding raised $ 25k | Total funding raised $ 19.5m |

BioLoomics is a preclinical-stage biotechnology company leveraging the directed evolution of antibodies in human cells to create target-degrading antibodies.
View company